Compare Adaptive Biotechnologies Corp (ADPT) vs Cintas Corporation (CTAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Cintas Corporation — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Cintas Corporation trades at $205.28 (market cap $82.15B). The key difference: Cintas Corporation is far larger — about 20.3× Adaptive Biotechnologies Corp's market cap, and Cintas Corporation pays a 1.01% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | CTAS | |
|---|---|---|
Market Cap | $4.04B | $82.15B |
Sector | Health | Industrials |
52-Week High | $25.45 | $225.10 |
52-Week Low | $12.30 | $163.55 |
Enterprise Value | $4.10B | $84.56B |
Dividend Yield | — | 1.01% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Cintas Corporation
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →
